Cargando…
Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation
Cancer immunotherapies often modulate macrophage effector function by introducing either targeting antibodies that activate Fcγ receptors (FcγRs) or blocking antibodies that disrupt inhibitory SIRPα-CD47 engagement. However, how these competing signals are integrated is poorly understood, raising qu...
Autores principales: | Suter, Emily C., Schmid, Eva M., Harris, Andrew R., Voets, Erik, Francica, Brian, Fletcher, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477956/ https://www.ncbi.nlm.nih.gov/pubmed/34433055 http://dx.doi.org/10.1016/j.celrep.2021.109587 |
Ejemplares similares
-
CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis
por: Liu, Ran, et al.
Publicado: (2017) -
Luteolin promotes macrophage-mediated phagocytosis by inhibiting CD47 pyroglutamation
por: Li, Zhiqiang, et al.
Publicado: (2021) -
HIV-1 Vpu Promotes Phagocytosis of Infected CD4(+) T Cells by Macrophages through Downregulation of CD47
por: Cong, Lijun, et al.
Publicado: (2021) -
CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis
por: Kojima, Yoko, et al.
Publicado: (2016) -
Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy
por: Zhu, Huaiyang, et al.
Publicado: (2017)